About
Molecular Diagnostics for Oncology
Areas of Focus
Categories
DiagnosticsChina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
720
By Status
UNKNOWN: 2RECRUITING: 1NOT_YET_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06622798Collaborator
Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients
N/ARecruiting
470 participants
Started: Aug 20, 2024 · Completed: Jul 7, 2026
NCT05848154Collaborator
Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer
N/ANot yet recruiting
92 participants
Started: Jun 1, 2023 · Completed: Jan 31, 2026
NCT05602831Collaborator
Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer
N/AUnknown
108 participants
Started: Aug 10, 2022 · Completed: Aug 31, 2024
NCT03546452Collaborator
A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC
N/AUnknown
50 participants
Started: May 18, 2018 · Completed: May 1, 2019
Locations (1)
Headquarters
Xiamen, China
Map
Loading map...